Jill Larsen
Physician Assistant · Ocean Springs, MSNPI 1861672909
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.0% of the total across 480 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 21.1% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in MS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 480 payments — averaging $16.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- AstraZeneca$723
- Lilly USA, LLC$620
- Abbott$546
- Novo Nordisk$418
- Pfizer$414
- plus $3K from 31 others
What the payments were for
- Food & beverage$7,71699%
- Education$801%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 98 | $1,646 |
| AstraZeneca | 41 | $723 |
| Lilly USA, LLC | 45 | $620 |
| Abbott | 43 | $546 |
| Novo Nordisk | 27 | $418 |
| Pfizer | 27 | $414 |
| Xeris Pharmaceuticals, Inc. | 18 | $360 |
| Renalytix AI, Inc. | 16 | $310 |
| GSK | 24 | $306 |
| Bayer | 15 | $289 |
| Dexcom, Inc. | 11 | $205 |
| Amarin Pharma, Inc. | 11 | $173 |
| Biohaven Pharmaceutical Holding Company Ltd. | 8 | $161 |
| Novartis | 8 | $147 |
| Amgen | 9 | $146 |
| Astellas Pharma US Inc | 5 | $137 |
| Corcept Therapeutics | 7 | $134 |
| Currax Pharmaceuticals LLC | 9 | $130 |
| Sanofi-aventis U.S. LLC | 7 | $127 |
| Boehringer Ingelheim | 8 | $119 |
| Biohaven Pharmaceuticals, Inc. | 6 | $97 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $83 |
| Medtronic | 5 | $79 |
| Exact Sciences | 4 | $62 |
| Merck | 3 | $61 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $60 |
| Teva Pharmaceuticals USA, Inc. | 4 | $57 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| Idorsia Pharmaceuticals US Inc | 2 | $37 |
| Cook Medical LLC | 1 | $16 |
| Arbor Pharmaceuticals, Inc. | 1 | $16 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
| GRT US Holding, Inc. | 1 | $15 |
| Adlon Therapeutics L.p. | 1 | $14 |
| Boston Scientific | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $11 |
| Genentech USA, Inc. | 1 | $6 |
How this compares
$7,795 in reported general payments places this provider in the 90th percentile of 278 physician assistant providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 121 | $157,464 |
| JardianceEmpagliflozin | 95 | $116,799 |
| MounjaroTirzepatide | 54 | $57,535 |
| TrulicityDulaglutide | 26 | $47,279 |
| FarxigaDapagliflozin Propanediol | 46 | $41,359 |
| RybelsusSemaglutide | 14 | $31,780 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 45 | $31,023 |
| EliquisApixaban | 21 | $25,293 |
| XareltoRivaroxaban | 31 | $25,188 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 26 | $18,364 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 17 | $14,124 |
| Tresiba Flextouch U-200Insulin Degludec | 18 | $13,259 |
| Tresiba Flextouch U-100Insulin Degludec | 22 | $8,607 |
| Repatha SureclickEvolocumab | 13 | $6,931 |
| Breo ElliptaFluticasone/Vilanterol | 18 | $6,413 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $418 | $189,244135 claims |
| Boehringer IngelheimJardiance | $119 | $116,79995 claims |
| Lilly USA, LLCMounjaro, Trulicity | $620 | $104,81580 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $723 | $63,74989 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $306 | $37,43663 claims |
| PfizerEliquis, Premarin | $414 | $29,59138 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 278 physician assistant providers in Mississippi.
Other physician assistant in Ocean Springs
- Karmen ClarkOcean Springs$49K
- Connie KlotzbachOcean Springs$20K
- Mary AdamsOcean Springs$13K
- Elizabeth HerouxOcean Springs$8K
- Rebecca GuiceOcean Springs$7K
- Lavinia DrambareanHattiesburg$382K
- Kristen RichardsonFlowood$21K
- Nichole HornHattiesburg$19K
- Hannah SavelyTupelo$13K
- Barry FlippoSouthaven$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.